PHOENIX, AZ (March, 2016) – Despite the popularity of foods with reduced or no sugar, Americans consume an average of 22 to 30 teaspoons a day and many are struggling with the metabolic consequences of excess — 69% are overweight or obese.Mineral Biosciences® GlyDe® D undercuts the sugar metabolism problem by defending against glycation.
What Is Glycation?
Most people know that eating too much sugar and starch raises blood sugar and if levels become chronically high, risk increases for many diseases and disorders. But there’s another, critical problem: Excess sugar combines with proteins and forms harmful rogue molecules called advanced glycation end products, or AGEs for short. Ironically, AGEs make a human body age faster, by damaging every type of cell, in nerves, organs, arteries, and the skin.
How GlyDe® D Works
GlyDe® D contains a one-of-a-kind ingredient, Totála® Ionic Mineral Complex, which is patented for treating or preventing glycation — a process formally known as anti-glycation. It defends against rogue AGEs. The ingredient is a proprietary composition of at least 68 major, minor, and trace minerals used by the human body for optimum function, including selenium, zinc, magnesium, calcium, iron, sodium, potassium, phosphorus, copper, silicon, boron, manganese, iodine, molybdenum, chromium, sulfur, strontium, and vanadium.
GlyDe® D is exceptionally well absorbed and utilized, because the minerals are extracted with a patented ionic process, which produces tiny molecules that dissolve more easily than colloidal or other types of minerals. In addition, the process delivers an unusually wide spectrum of natural minerals in a form that is readily transported throughout the human body.
Organic Mineral Sources
Millions of years ago, the minerals in GlyDe® D were parts of plants. Now, they are called “humic”, meaning they come from plant materials that have been transformed over time to become part of the soil. (“Humic” comes from “humi”, Latin for “on the ground.”) Mineral Biosciences® identifies and extracts especially rich veins of these deposits within the earth’s crust, in carefully selected locations in the United States.
Humic ingredients are accepted by the Organic Material Review Institute (OMRI), through the National Organic Program (NOP), and the United States Department of Agriculture (USDA). In addition, the company’s proprietary extraction process — which uses water but no solvents or other chemicals — certifiably complies with OMRI, NOP, and USDA organic standards.
Glycation can be detected with the same tests that measure chronic levels of blood sugar, and these have been used in studies of the patented mineral complex. When glycation decreases, so do levels of blood sugar, indicating healthier sugar metabolism.
A study published in the International Journal for Vitamin and Nutrition Research tested the proprietary mineral complex in GlyDe D on human cells and in diabetic mice. Researchers concluded: “To our best knowledge, this is the first description ever of a fossil material having anti-diabetic activity in pre-clinical models.” While GlyDe® D is not a treatment for diabetes, the research demonstrates that this patented extract has a beneficial effect on the metabolism of sugar.
GlyDe® D combines Totála® Ionic Mineral Complex with Vitamin D, as adequate levels of the vitamin are linked to healthy levels of blood sugar. The supplement is:
Serving Size: 1 softgel
Vitamin D3 (as cholecalciferol): 2,000 IU
Ionic Mineral Complex (Totála®): 300 mg
Use: Take one to two times daily, after meals
About Mineral Biosciences®
Mineral Biosciences® is an affiliate of the larger Global Organics® Group of companies. Founded over 20 years ago on the belief that “Nature Knows Best®,” Global Organics develops signature mineral products that are proven to enhance the health of people, animals, and the environment.
For more information about Mineral BioSciences, or to interview Managing Partner/CEO, Luke Blotsky, please contact David Jay at David@Christieand.co or call 805-969-3744. Visit www.glycationdefense.com.
Advanced glycation end products (AGEs) and their receptors (RAGEs) in diabetic vascular disease. Medicographia. Accessed March 7, 2016.
Anti-diabetic activity of a mineraloid isolate, in vitro and in genetically diabetic mice. Deneau J, Ahmed T, Blotsky R, Bojanowski K. International Journal for Vitamin and Nutrition Research. 2011 Jan;81(1):34-42. (Full study available on request.)